C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $143,385 | -47.8% | 45,664 | -1.9% | 0.00% | – |
| Q4 2022 | $274,498 | -31.9% | 46,525 | +1.2% | 0.00% | -100.0% |
| Q3 2022 | $403,000 | +14.5% | 45,995 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $352,000 | -46.0% | 46,718 | +73.8% | 0.00% | 0.0% |
| Q1 2022 | $652,000 | -35.1% | 26,885 | -13.8% | 0.00% | 0.0% |
| Q4 2021 | $1,004,000 | -24.4% | 31,191 | +4.9% | 0.00% | -50.0% |
| Q3 2021 | $1,328,000 | -26.1% | 29,732 | -37.4% | 0.00% | 0.0% |
| Q2 2021 | $1,797,000 | +201.0% | 47,489 | +194.2% | 0.00% | +100.0% |
| Q1 2021 | $597,000 | +11.6% | 16,140 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $535,000 | – | 16,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |